Skip to Content
286

Baxter International

  • Previous Rank283
  • Revenues ($M)$11,127.0
  • Revenue Percent Change5.4%
  • Profits ($M)$1,624.0
  • Profits Percent Change126.5%
  • Assets ($M)$15,641.0
  • Employees50,000

The biotech health care company makes devices and pharmaceuticals that treat hemophilia, immune disorders, infectious diseases, and kidney disease.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Jos� E. Almeida
CEO Title
Chairman, President & Chief Executive Officer
Sector
Health Care
Industry
Medical Products and Equipment
HQ Location
Deerfield, Ill.
Websitehttp://www.baxter.com
Years on Fortune 500 List49
Employees50,000

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$11,127.05.4%
Profits ($M)$1,624.0126.5%
Assets ($M)$15,641.0-
Total Stockholder Equity ($M)$7,794.0-

Profit Ratios

Profit as % of Revenues14.6%
Profits as % of Assets10.4%
Profits as % of Stockholder Equity20.8%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)2.97
EPS % Change (from 2017)130.2%
EPS % Change (5 year annual rate)-4.1%
EPS % Change (10 year annual rate)-0.6%

Total Return

Total Return to Investors (2018)2.8%
Total Return to Investors (5 year, annualized)13.4%
Total Return to Investors (10 year, annualized)10.6%